SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 6,546.05 |
| Enterprise Value ($M) | 7,058.18 |
| Book Value ($M) | 342.13 |
| Book Value / Share | 5.30 |
| Price / Book | 19.13 |
| NCAV ($M) | -151.40 |
| NCAV / Share | -2.35 |
| Price / NCAV | -43.24 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.15 |
| Return on Assets (ROA) | -0.15 |
| Return on Equity (ROE) | -0.50 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.75 |
| Current Ratio | 2.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 702.07 |
| Assets | 1,195.60 |
| Liabilities | 853.47 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 508.82 |
| Operating Income | -212.04 |
| Net Income | -67.09 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -192.59 |
| Cash from Investing | -47.50 |
| Cash from Financing | 273.11 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Avoro Capital Advisors LLC | 6.00 | ||
| 13G/A | Wellington Management Group Llp | 4.80 | -28.13 | |
| 13G/A | BlackRock, Inc. | 8.00 | -22.68 | |
| 13G/A | Fmr Llc | 3.50 | -48.31 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 8.50 | -13.82 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 193,389 | 698,295 | 27.69 | |
| 311,140 | 1,241,806 | 25.06 | |
| 205,574 | 790,806 | 26.00 | |
| 162,236 | 574,875 | 28.22 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BLUE – bluebird bio, Inc. | BMEA – Biomea Fusion, Inc. |
| BMRN – BioMarin Pharmaceutical Inc. | CABA – Cabaletta Bio, Inc. |
| CCCC – C4 Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io